BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang AJ, Lee AC, Chan JF, Liu F, Li C, Chen Y, Chu H, Lau SY, Wang P, Chan CC, Poon VK, Yuan S, To KK, Chen H, Yuen KY. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters. Clin Infect Dis 2021;72:e978-92. [PMID: 33216851 DOI: 10.1093/cid/ciaa1747] [Cited by in Crossref: 41] [Cited by in F6Publishing: 58] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Hwang JH, You YS, Yeom SW, Lee MG, Lee JH, Kim MG, Kim JS. Influenza viral infection is a risk factor for severe illness in COVID-19 patients: a nationwide population-based cohort study. Emerg Microbes Infect 2023;12:2164215. [PMID: 36580041 DOI: 10.1080/22221751.2022.2164215] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Maltezou HC, Papanikolopoulou A, Vassiliu S, Theodoridou K, Nikolopoulou G, Sipsas NV. COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature. Viruses 2023;15:865. [DOI: 10.3390/v15040865] [Reference Citation Analysis]
3 Wong A, Barrero Guevara LA, Goult E, Briga M, Kramer SC, Kovacevic A, Opatowski L, Domenech de Cellès M. The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps. PLoS Pathog 2023;19:e1011167. [PMID: 36888684 DOI: 10.1371/journal.ppat.1011167] [Reference Citation Analysis]
4 Farias LABG, Silva FJCD, Maia KM, Cavalcante KF, Damasceno LS. A fatal case of COVID-19-associated meningoencephalitis in a patient coinfected with influenza A. Rev Inst Med Trop Sao Paulo 2023;65:e22. [PMID: 36946818 DOI: 10.1590/S1678-9946202365022] [Reference Citation Analysis]
5 Elaiw AM, Alsulami RS, Hobiny AD. Global dynamics of IAV/SARS-CoV-2 coinfection model with eclipse phase and antibody immunity. Math Biosci Eng 2023;20:3873-917. [PMID: 36899609 DOI: 10.3934/mbe.2023182] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Takashita E, Watanabe S, Hasegawa H, Kawaoka Y. Are twindemics occurring? Influenza Other Respir Viruses 2023;17:e13090. [PMID: 36567444 DOI: 10.1111/irv.13090] [Reference Citation Analysis]
7 Gimenes Lima G, Portilho AI, De Gaspari E. Animal Models to Test SARS-CoV-2 Vaccines: Which Ones Are in Use and Future Expectations. Pathogens 2022;12. [PMID: 36678369 DOI: 10.3390/pathogens12010020] [Reference Citation Analysis]
8 Vilas Boas de Melo C, Peters F, van Dijken H, Lenz S, van de Ven K, Wijsman L, Gomersbach A, Schouten T, van Kasteren PB, van den Brand J, de Jonge J. Influenza Infection in Ferrets with SARS-CoV-2 Infection History. Microbiol Spectr 2022;10:e0138622. [PMID: 36301107 DOI: 10.1128/spectrum.01386-22] [Reference Citation Analysis]
9 Gu B, Yao L, Zhu X, Tang P, Chen C. Comparison of hospitalized patients with severe pneumonia caused by COVID-19 and influenza A (H7N9 and H1N1): A retrospective study from a designated hospital. Open Med (Wars) 2022;17:1965-72. [PMID: 36561841 DOI: 10.1515/med-2022-0610] [Reference Citation Analysis]
10 Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY. Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. Emerg Microbes Infect 2022;11:926-37. [PMID: 35259078 DOI: 10.1080/22221751.2022.2051753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Morimoto R, Matsubara C, Hanada A, Omoe Y, Ogata T, Isegawa Y. Effect of Structural Differences in Naringenin, Prenylated Naringenin, and Their Derivatives on the Anti-Influenza Virus Activity and Cellular Uptake of Their Flavanones. Pharmaceuticals (Basel) 2022;15. [PMID: 36558931 DOI: 10.3390/ph15121480] [Reference Citation Analysis]
12 Vink E, Davis C, MacLean A, Pascall D, McDonald SE, Gunson R, Hardwick HE, Oosthuyzen W, Openshaw PJM, Baillie JK, Semple MG, Ho A; ISARIC4C Investigators. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study. Open Forum Infect Dis 2022;9:ofac531. [PMID: 36381618 DOI: 10.1093/ofid/ofac531] [Reference Citation Analysis]
13 Samal J, Agarwal R, Soni A, Pandey A, Thapar S, Gupta E. Co-infection of SARS-CoV-2 with other respiratory pathogens in patients with liver disease. Access Microbiology 2022;4. [DOI: 10.1099/acmi.0.000456] [Reference Citation Analysis]
14 Cong B, Deng S, Wang X, Li Y. The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: A systematic review and meta-analysis. J Glob Health 2022;12. [DOI: 10.7189/jogh.12.05040] [Reference Citation Analysis]
15 Trifonova I, Christova I, Madzharova I, Angelova S, Voleva S, Yordanova R, Tcherveniakova T, Krumova S, Korsun N. Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection. Front Public Health 2022;10:959319. [PMID: 36117597 DOI: 10.3389/fpubh.2022.959319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pizzorno A, Padey B, Dulière V, Mouton W, Oliva J, Laurent E, Milesi C, Lina B, Traversier A, Julien T, Trouillet-Assant S, Rosa-Calatrava M, Terrier O. Interactions Between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human Nasal Epithelium. J Infect Dis 2022;226:2095-104. [PMID: 36031537 DOI: 10.1093/infdis/jiac357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Yang J, Gong Y, Zhang C, Sun J, Wong G, Shi W, Liu W, Gao GF, Bi Y. Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges. Innovation (Camb) 2022;3:100306. [PMID: 35992368 DOI: 10.1016/j.xinn.2022.100306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Weidmann MD, Berry GJ, Green DA, Wu F. Prevalence and clinical disease severity of respiratory co-infections during the COVID-19 pandemic. Advances in Molecular Pathology 2022. [DOI: 10.1016/j.yamp.2022.07.003] [Reference Citation Analysis]
19 Yuen TT, Chan JF, Yan B, Shum CC, Liu Y, Shuai H, Hou Y, Huang X, Hu B, Chai Y, Yoon C, Zhu T, Liu H, Shi J, Zhang J, Cai JP, Zhang AJ, Zhou J, Yin F, Yuan S, Zhang BZ, Chu H. Targeting ACLY efficiently inhibits SARS-CoV-2 replication. Int J Biol Sci 2022;18:4714-30. [PMID: 35874959 DOI: 10.7150/ijbs.72709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Oishi K, Horiuchi S, Minkoff JM, tenOever BR, Heise MT. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection. J Virol. [DOI: 10.1128/jvi.00765-22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
21 Yuan S, Ye ZW, Liang R, Tang K, Zhang AJ, Lu G, Ong CP, Man Poon VK, Chan CC, Mok BW, Qin Z, Xie Y, Chu AW, Chan WM, Ip JD, Sun H, Tsang JO, Yuen TT, Chik KK, Chan CC, Cai JP, Luo C, Lu L, Yip CC, Chu H, To KK, Chen H, Jin DY, Yuen KY, Chan JF. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters. Science 2022;:eabn8939. [PMID: 35737809 DOI: 10.1126/science.abn8939] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
22 Fratty IS, Reznik-balter S, Nemet I, Atari N, Kliker L, Sherbany H, Keller N, Stein M, Mendelson E, Mandelboim M. Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic. Front Microbiol 2022;13:902476. [DOI: 10.3389/fmicb.2022.902476] [Reference Citation Analysis]
23 Dejucq-Rainsford N. Is SARS-CoV-2-induced testicular damage in hamsters relevant? Nat Rev Urol 2022. [PMID: 35361928 DOI: 10.1038/s41585-022-00589-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 de Melo CVB, Peters F, van Dijken H, Lenz S, van de Ven K, Wijsman L, Gommersbach A, Schouten T, van Kasteren PB, Judith VDB, de Jonge J. Influenza infection in ferrets with SARS-CoV-2 infection history.. [DOI: 10.1101/2022.03.22.485425] [Reference Citation Analysis]
25 Li C, Ye Z, Zhang AJX, Chan JFW, Song W, Liu F, Chen Y, Kwan MYW, Lee ACY, Zhao Y, Wong BHY, Yip CCY, Cai JP, Lung DC, Sridhar S, Jin D, Chu H, To KKW, Yuen KY. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Intranasal or Intratesticular Route Induces Testicular Damage. Clin Infect Dis 2022;75:e974-90. [PMID: 35178548 DOI: 10.1093/cid/ciac142] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
26 Fage C, Hénaut M, Carbonneau J, Piret J, Boivin G. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells. Viruses 2022;14:395. [DOI: 10.3390/v14020395] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
27 Kong L, You R, Zhang D, Yuan Q, Xiang B, Liang J, Lin Q, Ding C, Liao M, Chen L, Ren T. Infectious Bronchitis Virus Infection Increases Pathogenicity of H9N2 Avian Influenza Virus by Inducing Severe Inflammatory Response. Front Vet Sci 2022;8:824179. [DOI: 10.3389/fvets.2021.824179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Piret J, Boivin G. Viral Interference between Respiratory Viruses. Emerg Infect Dis 2022;28:273-81. [DOI: 10.3201/eid2802.211727] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 24.0] [Reference Citation Analysis]
29 Yuan S, Ye Z, Liang R, Tang K, Zhang AJ, Lu G, Ong CP, Poon VK, Chan CC, Mok BW, Qin Z, Xie Y, Sun H, Tsang JO, Yuen TT, Chik KK, Chan CC, Cai J, Luo C, Lu L, Yip CC, Chu H, To KK, Chen H, Jin D, Yuen K, Chan JF. The SARS-CoV-2 Omicron (B.1.1.529) variant exhibits altered pathogenicity, transmissibility, and fitness in the golden Syrian hamster model.. [DOI: 10.1101/2022.01.12.476031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
30 Cox G, Gonzalez AJ, Ijezie EC, Rodriguez A, Miller CR, Van Leuven JT, Miura TA. Priming With Rhinovirus Protects Mice Against a Lethal Pulmonary Coronavirus Infection. Front Immunol 2022;13:886611. [PMID: 35711419 DOI: 10.3389/fimmu.2022.886611] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Quan C, Zhang Z, Ding G, Sun F, Zhao H, Liu Q, Ma C, Wang J, Wang L, Zhao W, He J, Wang Y, He Q, Carr MJ, Wang D, Xiao Q, Shi W. Seroprevalence of influenza viruses in Shandong, Northern China during the COVID-19 pandemic. Front Med 2022;16:984-90. [PMID: 36152125 DOI: 10.1007/s11684-022-0930-5] [Reference Citation Analysis]
32 S Tam J, Shu Y; Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Hong Kong, China, Asia Pacific Alliance for the Control of Influenza (APACI), South Melbourne, VIC, Australia, School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, Guangdong, China. . China CDC Weekly 2022;4:22-6. [DOI: 10.46234/ccdcw2021.228] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Guan Z, Chen C, Li Y, Yan D, Zhang X, Jiang D, Yang S, Li L. Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis. Front Public Health 2021;9:773130. [PMID: 34957025 DOI: 10.3389/fpubh.2021.773130] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
34 Halfmann P, Nakajima N, Sato Y, Takahashi K, Accola M, Chibo S, Fan S, Neumann G, Rehrauer W, Suzuki T, Kawaoka Y. SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters. J Infect Dis 2021:jiab587. [PMID: 34875072 DOI: 10.1093/infdis/jiab587] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
35 Neumann G, Kawaoka Y. Quo Vadis Influenza? China CDC Wkly 2021;3:1046-8. [PMID: 34934513 DOI: 10.46234/ccdcw2021.254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Zhou R, Wang P, Wong Y, Xu H, Lau S, Liu L, Mok BW, Peng Q, Liu N, Woo K, Deng S, Tam RC, Huang H, Zhang AJ, Zhou D, Zhou B, Chan C, Du Z, Yang D, Au K, Yuen K, Chen H, Chen Z. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination.. [DOI: 10.1101/2021.10.21.465252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Li C, Chen YX, Liu FF, Lee AC, Zhao Y, Ye ZH, Cai JP, Chu H, Zhang RQ, Chan KH, Chiu KH, Lung DC, Sridhar S, Hung IF, To KK, Zhang AJ, Chan JF, Yuen KY. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model. Clin Infect Dis 2021;73:e719-34. [PMID: 33515458 DOI: 10.1093/cid/ciab083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
38 Dhakal S, Ruiz-Bedoya CA, Zhou R, Creisher PS, Villano JS, Littlefield K, Ruelas Castillo J, Marinho P, Jedlicka AE, Ordonez AA, Bahr M, Majewska N, Betenbaugh MJ, Flavahan K, Mueller ARL, Looney MM, Quijada D, Mota F, Beck SE, Brockhurst J, Braxton AM, Castell N, Stover M, D'Alessio FR, Metcalf Pate KA, Karakousis PC, Mankowski JL, Pekosz A, Jain SK, Klein SL; Johns Hopkins COVID-19 Hamster Study Group. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model. mBio 2021;12:e0097421. [PMID: 34253053 DOI: 10.1128/mBio.00974-21] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 14.0] [Reference Citation Analysis]
39 Melano I, Kuo LL, Lo YC, Sung PW, Tien N, Su WC. Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection. Viruses 2021;13:1301. [PMID: 34372507 DOI: 10.3390/v13071301] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
40 Li H, Zhao X, Zhao Y, Li J, Zheng H, Xue M, Guo L, Zhou J, Yang J, Zuo Y, Chen Y, Yang Z, Fan Q, Qin L, Shi H, Liu L. H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice. Emerg Microbes Infect 2021;10:1156-68. [PMID: 34060982 DOI: 10.1080/22221751.2021.1938241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
41 Kristjánsson JM, Rolfsson Ó. Virucidal activity of a proprietary blend of plant-based oils (Viruxal) against SARS-CoV-2 and influenza viruses – an in vitro study.. [DOI: 10.1101/2021.05.31.446420] [Reference Citation Analysis]
42 Bao L, Deng W, Qi F, Lv Q, Song Z, Liu J, Gao H, Wei Q, Yu P, Xu Y, Qu Y, Li F, Xue J, Gong S, Liu M, Wang G, Wang S, Zhao B, Cong B, Qin C. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza. Signal Transduct Target Ther 2021;6:200. [PMID: 34016949 DOI: 10.1038/s41392-021-00618-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
43 Zhang BZ, Wang X, Yuan S, Li W, Dou Y, Poon VK, Chan CC, Cai JP, Chik KK, Tang K, Chan CC, Hu YF, Hu JC, Badea SR, Gong HR, Lin X, Chu H, Li X, To KK, Liu L, Chen Z, Hung IF, Yuen KY, Chan JF, Huang JD. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters. Emerg Microbes Infect 2021;10:874-84. [PMID: 33890550 DOI: 10.1080/22221751.2021.1921621] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
44 Stowe J, Tessier E, Zhao H, Guy R, Muller-Pebody B, Zambon M, Andrews N, Ramsay M, Lopez Bernal J. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. Int J Epidemiol 2021:dyab081. [PMID: 33942104 DOI: 10.1093/ije/dyab081] [Cited by in Crossref: 51] [Cited by in F6Publishing: 63] [Article Influence: 25.5] [Reference Citation Analysis]
45 Cromer D, Juno JA, Khoury D, Reynaldi A, Wheatley AK, Kent SJ, Davenport MP. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Nat Rev Immunol 2021;21:395-404. [PMID: 33927374 DOI: 10.1038/s41577-021-00550-x] [Cited by in Crossref: 141] [Cited by in F6Publishing: 144] [Article Influence: 70.5] [Reference Citation Analysis]
46 Cimolai N. The Complexity of Co-Infections in the Era of COVID-19. SN Compr Clin Med 2021;:1-13. [PMID: 33937631 DOI: 10.1007/s42399-021-00913-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
47 Wen L, Tang K, Chik KK, Chan CC, Tsang JO, Liang R, Cao J, Huang Y, Luo C, Cai JP, Ye ZW, Yin F, Chu H, Jin DY, Yuen KY, Yuan S, Chan JF. In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor. Int J Biol Sci 2021;17:1555-64. [PMID: 33907519 DOI: 10.7150/ijbs.59191] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
48 Michelitsch A, Wernike K, Ulrich L, Mettenleiter TC, Beer M. SARS-CoV-2 in animals: From potential hosts to animal models. Adv Virus Res 2021;110:59-102. [PMID: 34353482 DOI: 10.1016/bs.aivir.2021.03.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
49 Le Hingrat Q, Bouzid D, Choquet C, Laurent O, Lescure FX, Timsit JF, Houhou-Fidouh N, Casalino E, Lucet JC, Descamps D, Visseaux B. Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France. Influenza Other Respir Viruses 2021;15:425-8. [PMID: 33817971 DOI: 10.1111/irv.12853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
50 Winkler MS, Skirecki T, Brunkhorst FM, Cajander S, Cavaillon JM, Ferrer R, Flohé SB, García-Salido A, Giamarellos-Bourboulis EJ, Girardis M, Kox M, Lachmann G, Martin-Loeches I, Netea MG, Spinetti T, Schefold JC, Torres A, Uhle F, Venet F, Weis S, Scherag A, Rubio I, Osuchowski MF. Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge. EBioMedicine 2021;66:103291. [PMID: 33813139 DOI: 10.1016/j.ebiom.2021.103291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
51 To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR, Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect 2021;10:507-35. [PMID: 33666147 DOI: 10.1080/22221751.2021.1898291] [Cited by in Crossref: 86] [Cited by in F6Publishing: 63] [Article Influence: 43.0] [Reference Citation Analysis]
52 Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol 2021;21:245-56. [PMID: 33723416 DOI: 10.1038/s41577-021-00522-1] [Cited by in Crossref: 183] [Cited by in F6Publishing: 191] [Article Influence: 91.5] [Reference Citation Analysis]
53 Kostic C, Jesper A, Christ J, Christ S, Kutzner H. Rezidivierende Pseudo-T-Zell-Lymphom-ähnliche Effloreszenzen. Dtsch Dermatolog 2021;69:238-240. [DOI: 10.1007/s15011-021-4529-y] [Reference Citation Analysis]
54 Rothan HA, Teoh TC. Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro). Mol Biotechnol 2021;63:240-8. [PMID: 33464543 DOI: 10.1007/s12033-021-00299-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
55 Peng P, Hu J, Deng HJ, Liu BZ, Fang L, Wang K, Tang N, Huang AL. Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months. Cell Mol Immunol 2021;18:490-1. [PMID: 33420358 DOI: 10.1038/s41423-020-00605-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
56 Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021;19:141-54. [PMID: 33024307 DOI: 10.1038/s41579-020-00459-7] [Cited by in Crossref: 2083] [Cited by in F6Publishing: 2091] [Article Influence: 1041.5] [Reference Citation Analysis]
57 Su S, Du L, Jiang S. Learning from the past: development of safe and effective COVID-19 vaccines. Nat Rev Microbiol 2021;19:211-9. [PMID: 33067570 DOI: 10.1038/s41579-020-00462-y] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 45.0] [Reference Citation Analysis]
58 Mehrbod P, Hudy D, Shyntum D, Markowski J, Łos MJ, Ghavami S. Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus. Biomolecules 2020;11:E10. [PMID: 33374214 DOI: 10.3390/biom11010010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
59 Alon R, Sportiello M, Kozlovski S, Kumar A, Reilly EC, Zarbock A, Garbi N, Topham DJ. Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19. Nat Rev Immunol 2021;21:49-64. [PMID: 33214719 DOI: 10.1038/s41577-020-00470-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 24.0] [Reference Citation Analysis]
60 Khoury DS, Wheatley AK, Ramuta MD, Reynaldi A, Cromer D, Subbarao K, O'Connor DH, Kent SJ, Davenport MP. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol 2020;20:727-38. [PMID: 33139888 DOI: 10.1038/s41577-020-00471-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 25.0] [Reference Citation Analysis]
61 Paoli D, Pallotti F, Nigro G, Aureli A, Perlorca A, Mazzuti L, Di Carlo D, Turriziani O, Lenzi A, Lombardo F. Sperm cryopreservation during the SARS-CoV-2 pandemic. J Endocrinol Invest 2021;44:1091-6. [PMID: 33040303 DOI: 10.1007/s40618-020-01438-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
62 Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021;19:141-54. [PMID: 33024307 DOI: 10.1038/s41579-020-00459-7] [Cited by in Crossref: 950] [Cited by in F6Publishing: 7] [Article Influence: 316.7] [Reference Citation Analysis]